Content about Non-steroidal anti-inflammatory drug

December 10, 2012
American Heart Association joins NSAID education group

The American Heart Association has joined a group of patient and provider organizations promoting safe use of a commonly used class of painkillers.

EUGENE, Ore. — The American Heart Association has joined a group of patient and provider organizations promoting safe use of a commonly used class of painkillers.

The AHA announced that it had joined the Alliance for the Rational Use of NSAIDs, which refers to nonsteroidal anti-inflammatory drugs, a class that includes the common drug ibuprofen. Other members include the American Academy of Nurse Practitioners and the American Association of Colleges of Pharmacy.

September 1, 2011
Study: PPIs shift NSAID stomach damage to small intestine; probiotics possible solution

Proton-pump inhibitors may aggravate, not soothe, stomach discomfort created through chronic use of nonsteroidal anti-inflammatory drugs for such conditions as arthritis, according to research released Thursday.

HAMILTON, Ontario — Proton-pump inhibitors may aggravate, not soothe, stomach discomfort created through chronic use of nonsteroidal anti-inflammatory drugs for such conditions as arthritis, according to research released Thursday.

In a study published in the medical journal Gastroenterology, principal investigator John Wallace reported the extent of the hard-to-detect damage caused to the small intestine only recently has been discovered through use of small video cameras swallowed like pills.

April 28, 2011
APF expands PainSafe educational initiative with new information, resources

The American Pain Foundation on Wednesday launched new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs as part of its PainSafe educational initiative.

BALTIMORE — The American Pain Foundation on Wednesday launched new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs as part of its PainSafe educational initiative.

The new information will be launched with a national public service announcement emphasizing the safe use of pain treatment options, particularly medications containing NSAIDs (aspirin, ibuprofen and naproxen) and acetaminophen (Tylenol and APAP).

March 25, 2011
Study: Vimovo 'well-tolerated' among osteoarthritis patients

A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

NATIONAL HARBOR, Md. — A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

AstraZeneca announced results of PN400-304, a 12-month study of Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets in patients with osteoarthritis who need daily treatment with NSAIDs but are at risk of NSAID-related gastric ulcers. Vimovo is designed to reduce pain while reducing gastric ulcer risk.

March 3, 2011
NSAIDs could pose erectile dysfunction risk among men

Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

PASADENA, Calif. — Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

The study, sponsored by Kaiser Permanente and published online in the Journal of Urology, found that men who took nonsteroidal anti-inflammatory drugs, or NSAIDs, three times a day for more than three months were 2.4 times as likely to have erectile dysfunction as men who didn’t take the drugs regularly. The study used data from 80,966 men ages 45 to 69 years in California.

January 5, 2010
Study: NSAID may reduce skin cancer

A new study found that a nonsteroidal anti-inflammatory drug may reduce a patient's risk of...